Guangdong Association Of Clinical Trials
Clinical trials sponsored by Guangdong Association Of Clinical Trials, explained in plain language.
-
Smart blood tests guide lung cancer treatment in new trial
Disease control OngoingThis phase 3 study tests a two-step approach for people with a specific type of advanced lung cancer (EGFR-mutant, stage III). First, patients take a targeted pill called almonertinib. Then, based on a sensitive blood test (MRD) and team evaluation, they may get surgery or radiat…
Phase: PHASE3 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for lung cancer patients with brain spread: lorlatinib shows promise
Disease control OngoingThis study tests the drug lorlatinib in people with a specific type of lung cancer (ALK-positive) that has spread to the brain or the lining of the spinal cord. The goal is to see how well the drug shrinks tumors in the brain and controls the disease. About 41 adults will take pa…
Phase: PHASE4 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated May 05, 2026 11:54 UTC